Cisplatin effects on rhythmic functions of mice: Strain and tissue dependence

Chronobiology International

Volumn 29, Issue 6, 2012, Pages 724-735

  Weigl, Yuval ^a,b   Peleg, Leah ^a,b   Dotan, Aviva ^a   Ashkenazi, Israel E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

Circadian disruption; Circadian rhythm; Cisplatin; Genetic influences; Inbred strain; Mice; Re entrainment

Indexed keywords

CISPLATIN; CREATININE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CIRCADIAN RHYTHM; DRUG EFFECT; MALE; MOTOR ACTIVITY; MOUSE; PHYSIOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; CIRCADIAN RHYTHM; CISPLATIN; CREATININE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOTOR ACTIVITY;

MAMMALIA; MUS; RODENTIA;

EID: 84863188356     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2012.685137     Document Type: Article

References (56)

1. Ahowesso C, Li X-M, Zampero S, Peteri-Brunback B, Dulong S, Beau J, Hossard V, Filipski E, Delaunay, Claustrat B. (2011). Sex and dosing-time dependencies in irinotecan-induced circadian disruption. Chronobiol. Int. 28:458-470.
2. Arendt J, Minors DJ,Waterhouse JM. (1989). Basic concepts and implications. In Arendt J, Minors DS, Waterhouse JM (eds.). Biological rhythms in clinical practice. Cornwall: Wright, Butterworth and Co., 3-7.
3. Bjarnason GA, Jordan R. (2000). Circadian variation of cell proliferation and cell cycle protein expression in man: clinical implications. Prog. Cell Cycle Res. 4:193-206.
4. Block KI, Block PB, Fox SR, Birris JS, Feng AY, de la TorreM, Nathan D, Tothy P, Maki AK, Gyllenhaal C. (2009). Making circadian cancer therapy practical. Integr. Cancer Ther. 8:371-386.
5. Boulikas T, Vougiouka M. (2004). Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs. Oncol. Rep. 11:559-595.
6. Boven E, van der Vijgh WJ, Nauta MN, Schluper HMM, Pinedo HM. (1985). Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts. Cancer Res. 45:86-90. (Pubitemid 15196936)
7. Buijs RM, Kalsbeek A. (2001). Hypothalamic integration of central and peripheral clocks. Nat. Rev. Neurosci. 2:521-526. (Pubitemid 33676587)
8. Buresova M, Benesova O, Illnerova H. (1990). Aging alters resynchronization of the circadian system in rats after a shift of the lightdark cycle. Experientia 46:75-77.
9. Cho K. (2001). Chronic jet lag produces temporal lobe atrophy and spatial cognitive deficits. Nat. Neurosci. 4:567-568. (Pubitemid 32507369)
10. Davis FC, Viswanathan N. (1996). The effect of transplanting one or two suprachiasmatic nuclei on the period of the restored rhythm. J. Biol. Rhythms 11:291-301. (Pubitemid 126482858)
11. Earnest DJ, Liang FO, Ratcliff M, Cassone VM. (1999). Immortal time: circadian clock properties of rat suprachiasmatic cell lines. Science 283:693-695.
12. Filipski E, Li XM, Levi F. (2006). Disruption of circadian coordination and malignant growth. Cancer Causes Control 17:509-514
13. Gachon F, Nagoshi E, Brown SA, Ripperger J, Schibler U. (2004). The mammalian circadian timing system: from gene expression to physiology. Chromosoma 113:103-112. (Pubitemid 39386400)
14. Gibbs FP. (1981). Temperature dependence of rat circadian pacemaker. Am. J. Physiol. 241:R17-R20. (Pubitemid 11032621)
15. Grozdea J, Maret A, Vergnes H, Bourrouillou G, Verdier J, Martin J, Salvayre R, Colombies P. (1984). Cytochemical and biochemnical studies on neutrophile alkaline phosphatase in parents of trisomy 21 children. Hum. Genet. 67:313-316. (Pubitemid 15195892)
16. Haus E, Touitou Y. (1992). Principles of clinical chronobiology. In Haus E, Touitou Y (eds.). Biological rhythms in clinical and laboratory medicine. Berlin: Springer Verlag, 6-33.
17. Haus E, Lakatua DJ, Swoyer J, Sackett-Lundeen L. (1983). Chronobiology in hematology and immunology. Am. J. Anat. 168:467-517. (Pubitemid 14216770)
18. Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010). Influence of circadian time of hypertension on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629-1651.
19. Johnston SW, Ozols RF, Hamilton TC. (1993). Mechanism of drug resistance in ovarian cancer. Cancer 71:644-649. (Pubitemid 23021264)
20. Kennaway DJ. (1994). Effect of a phase advance of the light/dark cycle on pineal function and circadian running activity in individual rats. Brain Res. Bull. 33:639-644.
21. Knutsson A. (2003). Health disorders of shift workers. Occup. Med. (Lond). 53:103-108. (Pubitemid 36395629)
22. Levi F, Hrushesky WJ, Borch RF, Pleasants ME, Kennedy BJ, Halberg F. (1982). Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism. Cancer Treat. Rep. 66:1933-1938. (Pubitemid 13251606)
23. Levi F, Okyar A, Dulong S, Innominato PF, Clairambault J. (2010). Circadian timing in cancer treatments. Annu. Rev. Pharmacol. Toxicol. 50:377-421
24. Lewy H, Naor Z, Ashkenazi IE. (1999). From ultradian to infradian rhythms: LH release patterns in vitro. Chronobiol. Int. 16:441-450. (Pubitemid 29362567)
25. Lewy H, Ashkenazi IE, Touitou Y. (2005). Prolactin rhythms-oscillators response to photoperiodic cues is age and circadian time dependent. Neurobiol. Aging 26:125-133. (Pubitemid 39600597)
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurements with folin phenol reagent. J. Biol. Chem. 193:265-275.
27. Martinez-Nicolas A, Ortiz-Tudela E, Madrid JA, Rol MA. (2011). Crosstalk between environmental light and internal time in humans. Chronobiol. Int. 28:617-629.
28. Marumoto N, Murakami N, Kuroda H, Murakami T. (1996). Melatonin accelerates reentrainment of circadian locomotor activity rhythms to new light-dark cycles in the rat. Jpn. J. Physiol. 46:347-351. (Pubitemid 26398053)
29. Mohawk JA, Cashen K, Lee TM. (2005). Inhibiting cortisol response accelerates recovery from a photic phase shift. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:R221-R228. (Pubitemid 40023934)
30. Ohdo S. (2010). Chronotherapeutic strategy: rhythm monitoring, manipulation and disruption. Adv. Drug Deliv. Rev. 62:859-875.
31. Peleg L, Nesbitt MN, Ashkenazi IE. (1989). Strain dependent response of circadian rhythm during exposure to continuous illumination. Life Sci. 44:893-900. (Pubitemid 19085268)
32. Peleg L, Zvulunov A, Ashkenazi IE. (1995). Genetic control of biological rhythm: independent expression of each rhythm parameter. Life Sci. 56:1143-1149.
33. Poulis J, Roelfsema F, van der Heide D, Smeenk D. (1985). Resynchronization patterns for urinary rhythms in rats after light-dark shifts. Am. J. Physiol. 249:R402-R409. (Pubitemid 16202755)
34. Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652-1667.
35. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911-1929.
36. Puchalski W, Saarela S, Lynch GR. (1996). Reentrainment of motor activity and spontaneous neuronal activity in suprachiasmatic nucleus of Djungarian hamsters. J. Biol. Rhythms 11:302-310 (Pubitemid 126482859)
37. Rajaratnam SMW, Arendt J. (2001). Health in a 24-h society. Lancet 358:999-1005. (Pubitemid 32913531)
38. Redman JR, Armstrong SM. (1988). Reentrainment of rat circadian activity rhythms: effects of melatonin. J. Pineal Res. 5:203-215. (Pubitemid 18070031)
39. Reebs SG, Maillet D. (2003). Effect of cage enrichment on the daily use of running wheels by Syrian hamsters. Chronobiol. Int. 20:9-20. (Pubitemid 36288269)
40. Roemeling RV, Olshefski R, Langevin T, Berestka J, Reusch JJ, Reusch JE, Lakatua D, Wick MR, Hrushesky WJ. (1986). Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences. Chronobiol. Int. 3:55-64. (Pubitemid 17193582)
41. Sawaki Y, Nihonmatsu I, Kawamura H. (1984). Transplantation of the neonatal suprachiasmatic nuclei into rats with complete bilateral suprachiasmatic lesions. Neurosci. Res. 1:67-72. (Pubitemid 14061244)
42. Shearman LP, Weaver DR. (1999). Photic induction of Period gene expression is reduced in Clock mutant mice. Neuroreport 10:613-618. (Pubitemid 29333292)
43. Siddik ZH. (2003). Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279. (Pubitemid 37487159)
44. Sothern RB, Levi F. Haus E, Halberg F, Hrushesky WJ. (1989). Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. J. Natl. Cancer Inst. 81:135-145. (Pubitemid 19031331)
45. Ticher A, Ashkenazi IE, Reinberg AE. (1995). Preservation of the functional advantage of human time structure. FASEB J. 9:269-274.
46. van der Vijgh WJ. (1991). Clinical pharmacokinetics of carboplatin. Clin. Pharmacokinet. 21:242-261
47. van Hennik MB, van der Vijgh WJ, Klein I, Elferink F, Vermorken JB, Winograd B, Pinedo HM. (1987). Comparative pharmacokineticks of cisplatin and three analogues in mice and humans. Cancer Res. 47:6297-6301. (Pubitemid 18011081)
48. Wallimann T, Hemmer W. (1994). Creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 133-134:193-220 (Pubitemid 24276833)
49. Weigl Y, Peleg L, Dotan A, Ashkenazi IE. (2004). Gender-dependent differences in biological rhythms of mice. Life Sci. 75:857-868. (Pubitemid 38737422)
50. Weigl Y, Ashkenazi IE, Dotan A, Peleg L. (2010). Shapes and structures of biological rhythms: variability of phenotypes in two strains of mice and their progeny. Biol. Rhythm Res. 41:27-39.
51. Weinert D, Freyberg S, Touitou Y, Djeridane Y, Waterhouse JM. (2005). The phasing of circadian rhythms in mice kept under normal or short photoperiods. Physiol. Behav. 84:791-798. (Pubitemid 40693443)
52. Whyte MP. (1995). Hypophosphatasia. In Scriver CR, Beaudet AL, Sly WS, Valle D (eds.). The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 4095-4112.
53. Winget CM, DeRoshia CW, Markley CL, Holley DC. (1984). A review of human physiological and performance changes associated with desynchronosis of biological rhythms. Aviat. Space Environ. Med. 55:1085-1096. (Pubitemid 15192697)
54. Zee PC, Rosenberg RS, Turek FW. (1992). Effects of aging on entrainment and rate of resynchronization of circadian locomotor activity. Am. J. Physiol. 263:R1099-R1103.
55. Zeng ZL, Wu MW, Sun J, Sun YL, Cai YC, Huang YJ, Xian LJ. (2010). Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity. J. Biochem. 148:319-326.
56. Zvulunov A, Peleg L, Carlebach R, Ashkenazi IE. (2002). Chemotoxicity and survival of tumor-bearing mice under exposure to randomized photoperiodic regimen. Life Sci. 72:237-245. (Pubitemid 35335815)